Section I: Nano-Pharmacokinetics Current state of the art 1. Introduction 2. Nano-Pharmacokinetics (NPK): Current state of the art 3. Engineered Nanomaterials and Pharmacokinetics
Section II: Nano-Pharmacokinetics Clinical development 4. Nano-Pharmacokinetics: Bio distribution and toxicology 5. Biological systems and Nano-Pharmacokinetics 6. Nano-Pharmacokinetics Assessment
Section III: Nano-Pharmacokinetics and cancer 7. Clinical significance of nanomaterials in cancer treatment 8. Nano-Pharmacokinetics and Theranostics: Co relation 9. Nano-Pharmacokinetics key role in cancer theranostics 10. Nano-Pharmacokinetics key role in in vivo imaging Nano-pharmacokinetics, pharmacodynamics (PK/PD) and clinical relationship 11. Nano-Pharmacokinetics Preclinical to Clinical Translation 12. Current pre-clinical stage of Nano-Pharmacokinetics 13. Advances in Clinical translation of Nano-Pharmacokinetics 14. Future Outlook and Conclusion